Roy N, Guruprasad M R, Kondaiah P, Mann E A, Giannella R A, Visweswariah S S
Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India.
Eur J Biochem. 2001 Apr;268(7):2160-71. doi: 10.1046/j.1432-1327.2001.02101.x.
Guanylate cyclase C is the receptor for the bacterial heat-stable enterotoxins and guanylin family of peptides, and mediates its action by elevating intracellular cGMP levels. Potentiation of ligand-stimulated activity of guanylate cyclase C in human colonic T84 cells is observed following activation of protein kinase C as a result of direct phosphorylation of guanylate cyclase C. Here, we show that prolonged exposure of cells to phorbol esters results in a decrease in guanylate cyclase C content in 4beta-phorbol 12-myristate 13-acetate-treated cells, as a consequence of a decrease in guanylate cyclase C mRNA levels. The reduction in guanylate cyclase C mRNA was inhibited when cells were treated with 4beta-phorbol 12-myristate 13-acetate (PMA) in the presence of staurosporine, indicating that a primary phosphorylation event by protein kinase C triggered the reduction in RNA levels. The reduction in guanylate cyclase C mRNA levels was not due to alterations in the half-life of guanylate cyclase C mRNA, but regulation occurred at the level of transcription of guanylate cyclase C mRNA. Expression in T84 cells of a guanylate cyclase C promoter-luciferase reporter plasmid, containing 1973 bp of promoter sequence of the guanylate cyclase C gene, indicated that luciferase activity was reduced markedly on PMA treatment of cells, and the protein kinase C-responsive element was present in a 129-bp region of the promoter, containing a HNF4 binding element. Electrophoretic mobility shift assays using an oligonucleotide corresponding to the HNF4 binding site, indicated a decrease in binding of the factor to its cognate sequence in nuclear extracts prepared from PMA-treated cells. We therefore show for the first time that regulation of guanylate cyclase C activity can be controlled at the transcriptional level by cross-talk with signaling pathways that modulate protein kinase C activity. We also suggest a novel regulation of the HNF4 transcription factor by protein kinase C.
鸟苷酸环化酶C是细菌热稳定肠毒素和鸟苷蛋白家族肽的受体,并通过提高细胞内cGMP水平来介导其作用。由于鸟苷酸环化酶C的直接磷酸化,蛋白激酶C激活后可观察到人类结肠T84细胞中鸟苷酸环化酶C的配体刺激活性增强。在此,我们表明,细胞长期暴露于佛波酯会导致4β-佛波醇12-肉豆蔻酸酯13-乙酸酯处理的细胞中鸟苷酸环化酶C含量降低,这是鸟苷酸环化酶C mRNA水平降低的结果。当细胞在存在星形孢菌素的情况下用4β-佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)处理时,鸟苷酸环化酶C mRNA的减少受到抑制,这表明蛋白激酶C的一次磷酸化事件触发了RNA水平的降低。鸟苷酸环化酶C mRNA水平的降低不是由于鸟苷酸环化酶C mRNA半衰期的改变,而是发生在鸟苷酸环化酶C mRNA转录水平的调控。在T84细胞中表达包含鸟苷酸环化酶C基因1973 bp启动子序列的鸟苷酸环化酶C启动子-荧光素酶报告质粒,表明细胞经PMA处理后荧光素酶活性显著降低,并且蛋白激酶C反应元件存在于启动子的129 bp区域,其中包含一个肝细胞核因子4(HNF4)结合元件。使用与HNF4结合位点对应的寡核苷酸进行电泳迁移率变动分析表明,在从PMA处理的细胞中制备的核提取物中,该因子与其同源序列的结合减少。因此,我们首次表明,鸟苷酸环化酶C活性的调节可通过与调节蛋白激酶C活性的信号通路相互作用在转录水平上受到控制。我们还提出了蛋白激酶C对HNF4转录因子的一种新调控方式。